Your browser doesn't support javascript.
loading
Cardiovascular safety perceptions of sulfonylureas based on evidence / 中国糖尿病杂志
Chinese Journal of Diabetes ; (12): 573-576, 2017.
Article in Chinese | WPRIM | ID: wpr-618583
ABSTRACT
The relationship between Sulfonylureas(SUs) and cardiovascular (CV) risks has attracted great attention.Previous studies have illustrated that some SUs increase CV risk in type 2 diabetes (T2DM) patients;while others do not.Clinical studies have found that the CV risks of different SUs may be different.Compared with other SUs;glimepiride and gliclazide may have lower CV risks.Here we reviewed evidence-based CV safety of SUs and the recent research progress.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Diabetes Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Diabetes Year: 2017 Type: Article